Staurinz 25 mg Softgel Capsule 28's
₹22959.18*
MRP ₹27999
18% off
₹23799*
MRP ₹27999
15% CB
₹4200 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Staurinz 25 mg Softgel Capsule belongs to the group of medicines called protein kinase inhibitors used to treat acute myeloid leukaemia (AML). It is sometimes, also used to treat aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated haematological neoplasm (SM-AHN), or mast cell leukaemia (MCL).
Staurinz 25 mg Softgel Capsule contains Midostaurin, which works by blocking the action of kinase enzymes in abnormal cells and stops their division and growth. Thereby, it helps prevent the spread of cancer and mast cells.
Staurinz 25 mg Softgel Capsule may cause certain side effects such as nausea, vomiting, headache, fever, musculoskeletal pain, and upper abdominal pain. Most of these side effects may not require medical attention and resolve gradually over time. Do not be reluctant to talk with your doctor if any of the side effects persist or worsen. Take Staurinz 25 mg Softgel Capsule as prescribed by your doctor.
Discontinue taking Staurinz 25 mg Softgel Capsule and inform your physician if you observe any allergic reactions. Inform the doctor about your health condition and medications to rule out any side effects. Do not take Staurinz 25 mg Softgel Capsule if you are pregnant or breastfeeding. This medicine is not recommended for children as safety and effectiveness have not been established.
Staurinz 25 mg Softgel Capsule belongs to the group of medicines called protein kinase inhibitors used to treat acute myeloid leukaemia (AML) in patients who are FLT3 mutation-positive. It is also used to treat aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated haematological neoplasm (SM-AHN), or mast cell leukaemia (MCL). Staurinz 25 mg Softgel Capsule contains Midostaurin, which works by blocking the action of kinase enzymes in abnormal cells and stops their division and growth. Thereby, it helps prevent the spread of cancer and mast cells.
Do not take Staurinz 25 mg Softgel Capsule if you are allergic to any of its components, if you are taking medicines used to treat tuberculosis (rifampicin), epilepsy (carbamazepine or phenytoin), prostate cancer (enzalutamide), or herbal products (St. John’s Wort) or if you are pregnant or breastfeeding. Inform the doctor if you have any infections, heart disorders, lung, kidney or liver diseases. Seek immediate medical attention if you experience symptoms of low white blood cell count (fever, sore throat, mouth ulcers), lung problems (fever, chest pain, cough with or without mucous, trouble breathing or shortness of breath), or heart problems (chest pain or discomfort, fainting, dizziness, light-headedness, shortness of breath, blue discolouration of your lips, hands or feet, or swelling of your lower limbs).
Drug-Drug Interactions: Inform the doctor if you are taking medicines used to treat tuberculosis (rifampicin), epilepsy (carbamazepine or phenytoin), prostate cancer (enzalutamide), infections (ketoconazole, clarithromycin), HIV (ritonavir, efavirenz), depression (nefazodone, bupropion), control levels of fat in your blood (atorvastatin, rosuvastatin), muscle relaxant (tizanidine, chlorzoxazone), or herbal product used to treat depression (St. John’s Wort).
Drug-Food Interactions: Do not consume grapefruit and its juice during treatment with Staurinz 25 mg Softgel Capsule as it may significantly increase the blood levels of the medicine.
Drug-Disease Interactions: Inform the doctor if you have breathing or lung problems, irregular heartbeat, QT prolongation, infections, or liver or kidney disease.
Acute myeloid leukaemia: Acute myeloid leukaemia, also called acute myelogenous leukaemia or acute nonlymphocytic leukaemia, is the cancer of blood and bone marrow with excess immature white blood cells. Symptoms include fever, recurrent infections, fatigue, and easy bruising.
Aggressive systemic mastocytosis (ASM): It is a clonal mast cell disease characterised by the progressive growth of neoplastic cells in organs, leading to organopathy. Signs and symptoms include fatigue, nausea, abdominal pain, diarrhoea, bloating, skin redness, warmth, headache, low blood pressure, shortness of breath, and light-headedness.
Systemic mastocytosis with associated haematological neoplasm (SM-AHN): It is characterised by the abnormal accumulation of neoplastic mast cells in one or more organs, mainly the bone marrow, associated with another hematologic neoplasm of non-mast cell nature.
Mast cell leukaemia (MCL): It is characterised by abnormal growth and build-up of mast cells (a type of white blood cell produced by the bone marrow). Symptoms include low blood pressure, itchy skin, and rashes.
Alcohol
Consult your doctor
It is not known if alcohol affects Staurinz 25 mg Softgel Capsule . Please consult your doctor.
Pregnancy
Unsafe
Staurinz 25 mg Softgel Capsule is not recommended during pregnancy as it may harm your unborn baby. Therefore, if you are pregnant or planning for pregnancy, talk to the doctor for advice.
Breast Feeding
Unsafe
Staurinz 25 mg Softgel Capsule may harm the baby. Avoid breastfeeding during treatment with Staurinz 25 mg Softgel Capsule and for at least 4 months after stopping the treatment.
Driving
Caution
Staurinz 25 mg Softgel Capsule may cause dizziness and vertigo. Be cautious while driving or operating machinery.
Liver
Consult your doctor
If you have a pre-existing or a history of liver disease, inform your doctor before receiving Staurinz 25 mg Softgel Capsule . Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Kidney
Consult your doctor
If you have a pre-existing or a history of kidney disease, inform your doctor before receiving Staurinz 25 mg Softgel Capsule . Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Children
Caution
The safety and effectiveness of Staurinz 25 mg Softgel Capsule in children below 18 years have not been established.
Country of origin
Manufacturer/Marketer address
Product Substitutes